On June 18, 2024, Wuxi Bio announced that it had approved the grant of a total of 434,227 restricted shares to 9 employees under its restricted share incentive program, which will vest according to a certain schedule. The program aims to motivate employees to improve performance and efficiency without attached performance targets. The restricted shares granted will be vested in batches on the second, third, fourth, and fifth anniversaries of the grant. In addition, the program has a claw-back mechanism, under which unvested shares will be forfeited if the grantee's employment terminates or if the grantee commits a criminal offense. The board of directors has approved the grant and believes that it is in the best interest of the company and its shareholders. After the grant, there are still 208,941,951 restricted shares available for future grants.

On June 18, 2024, Wuxi Bio announced that it had approved the grant of a total of 434,227 restricted shares to 9 employees under its restricted share incentive program, which will vest according to a certain schedule. The program aims to motivate employees to improve performance and efficiency without attached performance targets. The restricted shares granted will be vested in batches on the second, third, fourth, and fifth anniversaries of the grant. In addition, the program has a claw-back mechanism, under which unvested shares will be forfeited if the grantee's employment terminates or if the grantee commits a criminal offense. The board of directors has approved the grant and believes that it is in the best interest of the company and its shareholders. After the grant, there are still 208,941,951 restricted shares available for future grants.